BRAINSTORM CELL THERAPEUTICS INC. 10-Q filing
Filed 2025-08-14 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001410578-25-001782
- Form type
- 10-Q
- CIK
- 0001137883
- Primary document
- https://www.sec.gov/Archives/edgar/data/1137883/000141057825001782/bcli-20250630x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BRAINSTORM CELL THERAPEUTICS INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-5.7M | - | - |
| Net Income | $-5.8M | - | - |
| Eps Basic | -0.77 | - | - |
| Eps Diluted | -0.77 | - | - |
| Cash And Equivalents | $824,000 | - | - |
| Total Assets | $2.6M | - | - |
| Total Liabilities | $8.6M | - | - |
| Shareholders Equity | $-6.1M | - | - |
| Operating Cash Flow | $-5.1M | - | - |